DRUGS TREATING EPILEPSY, FELINE DIABETES RECEIVE FDA APPROVAL

被引：0
|
作者：
Lederhouse, Coco
机构：
来源：
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION | 2023年 / 261卷 / 11期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
引用
收藏
页码：1617 / 1617
页数：1
相关论文
共 50 条
  • [31] Drugs for dementia should receive accelerated approval, says world envoy
    Limb, Matthew
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [32] FDA approach to the regulation of drugs for diabetes
    Fleming, A
    AMERICAN HEART JOURNAL, 1999, 138 (05) : S338 - S345
  • [33] The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care
    Jazowski, Shelley A.
    Winn, Aaron N.
    CURRENT DIABETES REPORTS, 2017, 17 (06)
  • [34] The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care
    Shelley A. Jazowski
    Aaron N. Winn
    Current Diabetes Reports, 2017, 17
  • [35] Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs
    Scott, Pamela E.
    Unger, Ellis F.
    Jenkins, Marjorie R.
    Southworth, Mary Ross
    McDowell, Tzu-Yun
    Geller, Ruth J.
    Elahi, Merina
    Temple, Robert J.
    Woodcock, Janet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (18) : 1960 - 1969
  • [36] Global consequences of the US FDA's accelerated approval of cancer drugs
    Akhade, Amol
    Sirohi, Bhawna
    Gyawali, Bishal
    LANCET ONCOLOGY, 2022, 23 (02): : 201 - 203
  • [37] FDA Approval of Obesity Drugs A Difference in Risk-Benefit Perceptions
    Morrato, Elaine H.
    Allison, David B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (11): : 1097 - 1098
  • [38] Review and Approval of Oncology and Hematology Drugs at FDA from 2005 to 2007
    不详
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (04)
  • [39] SHORTENED FDA-APPROVAL PROCESS WILL REQUIRE MORE VIGILANCE OF DRUGS
    CALMES, HM
    FORMULARY, 1995, 30 (07): : 409 - 409
  • [40] Should the FDA approval process for weight-loss drugs be modified?
    Hendricks, Ed J.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (21) : 2094 - 2095
12345